Novo Nordisk contracts South Africa’s Aspen to produce insulin for African nations

Novo Nordisk contracts South Africa's Aspen to produce insulin for Africa

Novo Nordisk has contracted Aspen Pharmacare to produce human insulin on its behalf in South Africa for export to African countries through a low-cost government tender system, the Danish drugmaker said on Tuesday.

Novo Nordisk contracts South Africa’s Aspen to produce insulin for African nations

By Maggie Fick LONDON (Reuters) - Novo Nordisk has contracted Aspen Pharmacare to produce human insulin on its behalf in South Africa for export to African countries through a low-cost government tender system, the Danish drugmaker said on Tuesday. Announcing the deal on the sidelines of the United Nations General Assembly in New York, Novo said the contract will lead to the production of 16 million vials of insulin next year, marking its "e…

Novo Nordisk contracts Aspen to produce insulin for Africa

Output in 2024 will amount to the annual consumption of 1.1-million people with type 1 and 2 diabetes